Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ester Bonastre"'
Autor:
Montse Sanchez-Cespedes, David Pisano, Manel Esteller, Diana Salinas-Chaparro, Jose R. Hernandez Mora, Anna Esteve-Codina, Marc Dabad, Sophia Derdak, Gonzalo Gomez-Lopez, Osvaldo Graña, Ana Aza, Sebastian Moran, Ester Bonastre, Eva Pros, Pol Gimenez-Xavier
'Supplementary Methods'
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d0cfb60fba96b5576acadebd4f316ae
https://doi.org/10.1158/1535-7163.22504333
https://doi.org/10.1158/1535-7163.22504333
Autor:
Montse Sanchez-Cespedes, David Pisano, Manel Esteller, Diana Salinas-Chaparro, Jose R. Hernandez Mora, Anna Esteve-Codina, Marc Dabad, Sophia Derdak, Gonzalo Gomez-Lopez, Osvaldo Graña, Ana Aza, Sebastian Moran, Ester Bonastre, Eva Pros, Pol Gimenez-Xavier
Captions for supplementary Figures and Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06093fffd7e4e38839d1579f4e544a3e
https://doi.org/10.1158/1535-7163.22504327
https://doi.org/10.1158/1535-7163.22504327
Autor:
Montse Sanchez-Cespedes, David Pisano, Manel Esteller, Diana Salinas-Chaparro, Jose R. Hernandez Mora, Anna Esteve-Codina, Marc Dabad, Sophia Derdak, Gonzalo Gomez-Lopez, Osvaldo Graña, Ana Aza, Sebastian Moran, Ester Bonastre, Eva Pros, Pol Gimenez-Xavier
Supplementary Figure S1. Cell viability and colony formation assays of the indicated cell lines. Supplementary Figure S2. Multidimensional scaling plots Supplementary Figure S3. Cell viability assays and western blots
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7777dce197f683fa8c6d3b71abf1f833
https://doi.org/10.1158/1535-7163.22504324
https://doi.org/10.1158/1535-7163.22504324
Autor:
Montse Sanchez-Cespedes, David Pisano, Manel Esteller, Diana Salinas-Chaparro, Jose R. Hernandez Mora, Anna Esteve-Codina, Marc Dabad, Sophia Derdak, Gonzalo Gomez-Lopez, Osvaldo Graña, Ana Aza, Sebastian Moran, Ester Bonastre, Eva Pros, Pol Gimenez-Xavier
TABLE S1. Sequences used for primers and for the shRNAs. TABLE S2. List of genes selected from the WES, RNA-seq and microarray methylation analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fd2858a0dc911ce73880b22c4df6e79
https://doi.org/10.1158/1535-7163.22504330.v1
https://doi.org/10.1158/1535-7163.22504330.v1
Autor:
Montse Sanchez-Cespedes, Suvi Savola, Elisabeth Brambilla, Luca Roz, Alberto Villanueva, David Sidransky, Agustin Vidal, Enric Condom, Julian Carretero, Juan Pablo Rodrigo, Maria Dolores Chiara, Sylvie Lantuejoul, Federica Facchinetti, Ilse Zondervan, Sara Verdura, Ester Bonastre
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ee1732894d3483be3ba29191ba67eaf
https://doi.org/10.1158/0008-5472.22406970
https://doi.org/10.1158/0008-5472.22406970
Autor:
Montse Sanchez-Cespedes, Suvi Savola, Elisabeth Brambilla, Luca Roz, Alberto Villanueva, David Sidransky, Agustin Vidal, Enric Condom, Julian Carretero, Juan Pablo Rodrigo, Maria Dolores Chiara, Sylvie Lantuejoul, Federica Facchinetti, Ilse Zondervan, Sara Verdura, Ester Bonastre
Figure S1. PARD3-inactivation in the H157 lung cancer cell line. Figure S2. Ratio charts of the multiplex ligation-dependent probe amplification (MLPA) depicting a large intragenic deletion (from exon 4 to 23) in one of the LSCCs but not a normal DNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52cb1fb5d0134e1db3bfa1fba225608d
https://doi.org/10.1158/0008-5472.22406967.v1
https://doi.org/10.1158/0008-5472.22406967.v1
Autor:
Montse Sanchez-Cespedes, Suvi Savola, Elisabeth Brambilla, Luca Roz, Alberto Villanueva, David Sidransky, Agustin Vidal, Enric Condom, Julian Carretero, Juan Pablo Rodrigo, Maria Dolores Chiara, Sylvie Lantuejoul, Federica Facchinetti, Ilse Zondervan, Sara Verdura, Ester Bonastre
Correct apicobasal polarization and intercellular adhesions are essential for the appropriate development of normal epithelia. Here, we investigated the contribution of the cell polarity regulator PARD3 to the development of lung squamous cell carcin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::559b2be3367982241a60c0ba6305cf36
https://doi.org/10.1158/0008-5472.c.6507201.v1
https://doi.org/10.1158/0008-5472.c.6507201.v1
Autor:
Montse Sanchez-Cespedes, Suvi Savola, Elisabeth Brambilla, Luca Roz, Alberto Villanueva, David Sidransky, Agustin Vidal, Enric Condom, Julian Carretero, Juan Pablo Rodrigo, Maria Dolores Chiara, Sylvie Lantuejoul, Federica Facchinetti, Ilse Zondervan, Sara Verdura, Ester Bonastre
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61596ac5a09d4c404401c0c490301fc8
https://doi.org/10.1158/0008-5472.22406964.v1
https://doi.org/10.1158/0008-5472.22406964.v1
Autor:
Montse Sanchez-Cespedes, Suvi Savola, Elisabeth Brambilla, Luca Roz, Alberto Villanueva, David Sidransky, Agustin Vidal, Enric Condom, Julian Carretero, Juan Pablo Rodrigo, Maria Dolores Chiara, Sylvie Lantuejoul, Federica Facchinetti, Ilse Zondervan, Sara Verdura, Ester Bonastre
Table S1. List of lung cancer cell lines and histopathological type used to determine the status of the PARD3. Table S2. List of primers used for cloning, PCR and Sanger sequencing of PARD3. Table S3. List of single nucleotide polymorphisms (SNPs) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03ac94557b5ed0a0bca1f1010ffd36ae
https://doi.org/10.1158/0008-5472.22406961
https://doi.org/10.1158/0008-5472.22406961
Autor:
Manel Esteller, Jose Ramon Hernandez Mora, Sophia Derdak, Montse Sanchez-Cespedes, Anna Esteve-Codina, Diana Salinas-Chaparro, Eva Pros, Sebastian Moran, Ana Aza, David G. Pisano, Marc Dabad, Gonzalo Gómez-López, Pol Gimenez-Xavier, Osvaldo Graña, Ester Bonastre
Publikováno v:
Molecular Cancer Therapeutics. 16:1366-1376
The development of resistance to tyrosine kinase inhibitors (TKI) limits the long-term efficacy of cancer treatments involving them. We aimed to understand the mechanisms that underlie acquired resistance (AR) to MET inhibitors in lung cancer. EBC1 c